Pharmacokinetic-pharmacodynamic modeling of the anticancer effect of erlotinib in a human non-small cell lung cancer xenograft mouse model

AIM: Erlotinib is used to treat non-small-cell lung cancer (NSCLC), which targets epidermal growth factor receptor (EGFR) tyrosine kinase. The aim of this study was to investigate the relationship between erlotinib plasma concentrations and phosphorylated EGFR (pEGFR) levels, as well as the relation...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Wu, Qiong, Li, Meng-yao, Li, Han-qing, Deng, Chen-hui, Li, Liang, Zhou, Tian-yan, Lu, Wei
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2013
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4006468/
https://ncbi.nlm.nih.gov/pubmed/24096601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2013.101
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi